Table 2.
HCWs' history of COVID-19 infection, COVID-19 vaccine uptake, and vaccination attitudes with the willingness to get an annual COVID booster vaccine (n = 919)
| Total n (%) | Annual COVID-19 booster vaccine | P-value* | ||
|---|---|---|---|---|
| Acceptant | Hesitant | |||
| Previous COVID-19 | ||||
| Yes | 580 (63.3%) | 196 (33.8%) | 384 (66.2%) | .631 |
| No | 335 (36.6%) | 108 (32.2%) | 227 (67.8%) | |
| Dealt with post-vaccination severe COVID-19 cases | ||||
| Yes | 529 (58.7%) | 186 (34.5%) | 353 (65.5%) | .447 |
| No | 380 (41.3%) | 122 (32.1%) | 258 (67.9%) | |
| COVID-19 vaccination | ||||
| Yes | 722 (78.6%) | 270 (37.4%) | 452 (62.6%) | < .001 |
| No | 197 (21.4%) | 38 (19.3%) | 159 (80.7%) | |
| Side effects of COVID-19 vaccine | ||||
| Yes | 412 (42.9%) | 143 (34.7%) | 269 (65.3%) | .085 |
| No | 310 (57.1%) | 127 (41.0%) | 183 (59.0%) | |
| Received annual influenza vaccine | ||||
| Yes | 123 (13.4%) | 70 (56.9%) | 53 (43.1%) | < .001 |
| No | 796 (86.6%) | 238 (29.9%) | 558 (70.1%) | |
| Mistrust of vaccine benefits (Mean ± SD) | 9.2 ± 3.9 | 6.6 ± 2.7 | 10.6 ± 3.8 | < .001 |
| Worries over future effects (Mean ± SD) | 14.2 ± 3.2 | 13.7 ± 2.8 | 14.4 ± 3.2 | .002 |
| Concerns about commercial profits (Mean ± SD) | 10.8 ± 4.0 | 9.5 ± 4.0 | 11.4 ± 3.9 | .242 |
| Preference for natural immunity (Mean ± SD) | 12.4 ± 3.9 | 11.3 ± 3.8 | 12.9 ± 3.8 | .936 |
*Chi-squared test and independent t-test